Cancer

Cancer 01 Jan 2013

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older.

This study will evaluate the immune responses, safety and efficacy of the investigational HPV vaccine in women who are 26 years of age or older. Infection with human papilloma virus (HPV) has been clearly established as the central cause of cervical cancer. Official Title A Study to Evaluate the Safety,…
New Treatments for Prostate Cancer-How Do I Choose?
Cancer 01 Jan 2013

New Treatments for Prostate Cancer-How Do I Choose?

The many new treatments now available for localised prostate cancer make it more difficult to choose which is the best treatment. Options include radical prostatectomy in all its various forms, including nerve-sparing, non-nerve-sparing and non-nerve-sparing with sural nerve graft and robotic assisted laparoscopic surgery. It also includes conformal external beam…
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma.
Cancer 01 Jan 2013

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma.

The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of nodular basal cell carcinoma. Official Title A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 &…
Cancer 01 Jan 2013

PI-88 and/or Dacarbazine in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery

PI-88 may stop the growth of tumour cells by blocking blood flow to the tumour. Drugs used in chemotherapy, such as dacarbazine, work in different ways to stop the growth of tumour cells, either by killing the cells or by stopping them from dividing. Giving PI-88 together with dacarbazine may…
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
Cancer 01 Jan 2013

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small…
Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy
Cancer 01 Jan 2013

Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy

Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy medical clinical research trials
Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer
Cancer 01 Jan 2013

Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer

Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer clinical research medical trial
Lung Tumour Volume Database
Cancer 01 Jan 2013

Lung Tumour Volume Database

Lung Tumour Volume Database clinical trials medical research
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Cancer 01 Jan 2013

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer